Evidence map›Paper›PMID 30297632›Full record

ArticleMolecules (Basel, Switzerland)2018

Systematic Screening of Commonly Used Commercial Transfection Reagents towards Efficient Transfection of Single-Stranded Oligonucleotides.

Tao Wang, Leon M Larcher, Lixia Ma, Rakesh N Veedu

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

112 citing papers in PubMed, 1 synthesis or guideline pooled it, 213 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Design andMaterials today. Bio · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Tao WangCentre for Comparative Genomics, Murdoch University, Perth, WA 6150, Australia. Tao.Wang@murdoch.edu.au.
Leon M LarcherCentre for Comparative Genomics, Murdoch University, Perth, WA 6150, Australia. LeonMaria.Larcher@murdoch.edu.au.
Lixia MaSchool of Statistics, Henan University of Economics and Law, Zhengzhou 450046, China. realmlx@163.com.
Rakesh N VeeduCentre for Comparative Genomics, Murdoch University, Perth, WA 6150, Australia. R.Veedu@murdoch.edu.au.
Murdoch University · AUHenan University of Economic and Law · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-viral vector-mediated transfection is a core technique for in vitro screening of oligonucleotides. Despite the growing interests in the development of oliogonucleotide-based drug molecules in recent years, a comprehensive comparison of the transfection efficacy of commonly used commercial transfection reagents has not been reported. In this study, five commonly used transfection reagents, including Lipofectamine 3000, Lipofectamine 2000, Fugene, RNAiMAX and Lipofectin, were comprehensively analyzed in ten cell lines using a fluorescence imaging-based transfection assay. Although the transfection efficacy and toxicity of transfection reagents varied depending on cell types, the toxicity of transfection reagents generally displayed a positive correlation with their transfection efficacy. According to our results, Lipofectamine 3000, Fugene and RNAiMAX showed high transfection efficacy, however, RNAiMAX may be a better option for majority of cells when lower toxicity is desired. The transfection efficacy of Lipofectamine 2000 was compromised by its high toxicity, which may adversely affect its application in most cells. We firmly believe that our findings may contribute to the future In vitro delivery and screening of single-stranded therapeutic oligonucleotides such as antisense oligonucleotides, antimiRs, and DNAzymes.

Indexed as

TransfectionCell LineCell SurvivalDNA, Single-StrandedGenetic VectorsHumansLipidsOligonucleotidesPhosphatidylethanolamines1,2-dielaidoylphosphatidylethanolamineDNA, Single-StrandedFuGeneLipidsLipofectamineOligonucleotidesPhosphatidylethanolaminescationic lipidcytotoxicitygene transfectionsingle-stranded oligonucleotidetransfection reagent

Identifiers

PMID30297632
PMCPMC6222501
OpenAlexW2895206644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.